Trial

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects

Study Director
Start Date
1 / 2015
Trial Phase
Phase I
Trial Status
all patients enrolled
Current Enrollment
Target Enrollment
48
Overview
Completed A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
Phase: Phase 1
Number Enrolled: 48
NCT Number: NCT02288481
Other IDs: TBA-354-CL-001
Study Start: January 2015
Primary Completion: June 2015
Study Completion: June 2015
Last Verified: March 2016
Related Links
Developer Associations
TB Alliance
Compound Associations
TBA-354